3.305
price down icon1.49%   -0.05
after-market Dopo l'orario di chiusura: 3.30 -0.005 -0.15%
loading

Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
0.31%
15.42
15.47 17.10 18.84 19.10
Nonoperating Income/Loss
13.44%
1.643
1.898 2.064 2.231 2.654
Income/Loss From Continuing Operations Before Tax
1.52%
-13.78
-13.57 -15.03 -16.61 -16.45
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
1.52%
-13.78
-13.57 -15.03 -16.61 -16.45
Net Income/Loss
1.52%
-13.78
-13.57 -15.03 -16.61 -16.45
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.97%
0.038
126.31 126.20 126.14 125.45
Diluted Average Shares
99.97%
0.038
126.31 126.20 126.14 125.45
Basic Earnings Per Share
0.00%
-0.11
-0.11 -0.12 -0.13 -0.13
Diluted Earnings Per Share
0.00%
-0.11
-0.11 -0.12 -0.13 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$99.12
price up icon 0.49%
$28.33
price up icon 1.76%
$48.57
price up icon 0.16%
$91.18
price up icon 1.97%
ONC ONC
$310.79
price up icon 0.76%
$162.43
price down icon 1.47%
Capitalizzazione:     |  Volume (24 ore):